Our findings now suggest that aberrant ROCK2 activation, by blocking the proteasome-dependent degradation of MYC, can promote increased MYC protein levels in ABC-DLBCL potentially leading to its over-expression. The gene discussed is ROCK2; the disease is aneurysmal bone cyst.